openPR Logo
Press release

7 Key Takeaways from SMi’s 10th Annual Pharmaceutical Microbiology Conference

11-26-2021 04:22 PM CET | Health & Medicine

Press release from: SMi Group

Microbiology, Pharmaceutical Microbiology, Pharmaceuticals, Aseptic Technique, Sterility, Bioburden, Mycoplasma, Quality Control

Microbiology, Pharmaceutical Microbiology, Pharmaceuticals, Aseptic Technique, Sterility, Bioburden, Mycoplasma, Quality Control

SMi Reports: SMi Group outlines seven key takeaways attendees can gain from joining the Pharmaceutical Microbiology Conference on 17 and 18 January 2021 in London, UK.

The 10th Annual Pharmaceutical Microbiology Conference will convene on the 17th and 18th January 2022 in London, UK. Developing on previous conference success, SMi's 10th Annual Pharmaceutical Microbiology Conference will bring together industry experts to discuss and analyse the latest advancements and challenges within pharmaceutical microbiology.

The two-day conference is led by senior microbiologists engaged in research and the 2022 event will provide an unmatched platform for the meaningful exchange of ideas dealing with delivering information on rapid microbial methods, sterility assurance, contamination control and mycoplasma testing, updates on Annex 1 and much more.

Interested parties can register for the conference and the two interactive workshops at http://www.pharma-microbiology.com/PR3. Register by 30th November to save £100.

SMi Group are delighted to share seven key takeaways which delegates stand to gain by attending this vital must attend conference:

1. Contamination Control Strategy - a wholistic way to maintain sterility assurance - delving into Current status of EU GMP Annex-1, Elements of a CCS and contaminants in scope and looking to CCS hierarchy, structure, and lifecycle by Boehringer Ingelheim
2. A risk assessment approach to address fungal spore contamination in a cell and gene therapy cleanroom from STERIS Corporation
3. Annex 1 and Environmental Monitoring Program - implementation and justification of the best practices in routine by Sanofi
4. A Sanofi Pasteur Mycoplasma techno roadmap and implementation of mycoplasma alternative method to release human vaccines, looking into regulatory background and Mycoplasma testing, development of NAT methods, validation of NAT method for mycoplasma testing and a roadmap and Implementation for new vaccines and commercialized product
5. Explore alternative endotoxin test methods for products exhibiting low current state of Pyrogen - and Endotoxin Testing presented by Paul Ehrlich Institute
6. Hear from AstraZeneca on applying virtual reality to training in aseptic processing and microbiology
7. Panel Debate discussion on Diversity in Science: the importance of workplace diversity in life sciences

The conference will be chaired by Conference Chair: Di Morris, Clinical Auditor, AstraZeneca

Featured Speakers Include:
• Karen Capper, Associate Director - Head of Microbiology, Pharmaceutical Development, AstraZeneca
• Suzanne Nutter, QA Group Manager, AstraZeneca
• Benoit Ramond, Head of Microbiology and Sterile Technologies, Sanofi
• Martin Müllner, Senior Quality Assurance Manager, Boehringer Ingelheim
• Jim Polarine, Senior Technical Service Manager, STERIS
• Thierry Bonnevay Global Microbiology Analytical Expert, Sanofi Pasteur
• Johannes Oberdörfer, Lead Scientist Rapid Microbiology Methods, Boehringer Ingelheim
• Peter Annel, Principal Scientist, Novo Nordisk
• Ingo Spreitzer, Deputy Head, Section 1/3 Microbiological Safety, Paul-Ehrlich-Institut
• Ren-Yo Forng, Scientific Director, Amgen
• Pratixa Patel, Head of Analytical, Microbiology, Stability & Product Chemistry, GSK
• Sven Deutschmann, Head of Global ASAT, Roche
• Andrew Davies, Managing Director, Microgenetics
• David Collins, Global Technical Consultant, Life Sciences, ECOLAB
• Shabnam Solati, CEO, CTL-MAT

The full agenda and speaker line-up is available to download online at http://www.pharma-microbiology.com/PR3

The conference is proudly sponsored by: C.T.L. Mat, ECOLAB, Microgenetics, Novatek and NPC

For sponsorship enquiries contact Alia Malick, Director on +44 (0)20 7827 6164 or amalick@smi-online.co.uk

For media enquiries and press pass requests, contact Simi Sapal, Head of Marketing on +44 (0) 20 7827 6162 or ssapal@smi-online.co.uk

SMi’s 10th Annual Pharmaceutical Microbiology Conference
Conference: 17 - 18 January 2022
Workshops: 19 January 2022
London, UK
http://www.pharma-microbiology.com/PR3
#SMiPharmaMicroUK

London, UK
London

About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release 7 Key Takeaways from SMi’s 10th Annual Pharmaceutical Microbiology Conference here

News-ID: 2476609 • Views: 381

More Releases from SMi Group

Registration is open for SMi’s 5th Annual Pharmaceutical Microbiology East Coa …
SMi Group reports: The 5th Annual Pharmaceutical Microbiology East Coast Conference is set to return in April 2022 with a key focus existing methods and novel tools in microbial control to assure continuity in product quality and patient safety. SMi Group is delighted to announce the 5th Annual Pharmaceutical Microbiology East Coast Conference, taking place on the 27th and 28th April 2022 in Boston, USA. The 2022 Conference theme is
SMi’s 10th Annual Pharmaceutical Microbiology UK Conference - A Virtual Confer …
SMi Reports: SMi Group have made the decision to open the microbiology conference and workshops to all microbiologists by transforming it into a virtual-remote online access event only on 17th and 18th January 2022. SMi’s 10th Annual Pharmaceutical Microbiology UK Conference will no longer take place in London, UK. Instead, the conference is taking place on 17 and 18 January 2022 and will open its doors to a global audience delivering
Co-chairs Philip Hewitt and Stefan Pryzyborski, invitation to join SMi’s 5th A …
SMi Group reports: Co-Chairs, Philip Hewitt and Stefan Pryzyborski for SMi’s 5th Annual 3D Cell Culture invite industry professionals to join the conference in February 2022. Philip Hewitt, Global Head of Early Investigative Toxicology, Merck and Stefan Przyborski, Professor in Cell Technology, Durham University invite industry professionals by releasing invite letter to join SMi’s 5th Annual 3D Cell Culture Conference 2022. This event will convene on February 9th – 10th 2022,
SMi Group launches Robotics & Automation in Pharma Conference 2022 in London, UK
SMi Group reports: The inaugural Robotics and Automation Conference is convening on 21st and 22nd February 2022, in London, UK, with a key focus on significant leaps in the robotic automation field. SMi Group are delighted to announce the launch of the inaugural Robotics and Automation in Pharma conference, taking place on 21st and 22nd February 2022 in London, UK. The 2022 conference theme is on the latest developments in the

All 5 Releases


More Releases for Microbiology

Microbiology Webinars
Conference Series LLC LTD, the world's leading Scientific Event Organizer invites all the Speakers, Delegates, Researchers, Students and Industrialists to attend 49th World Congress on Microbiology (Microbiology Webinar) on June 15 around the theme Fostering developments and applications in Microbiology. URL: https://europe.microbiologyconferences.com/ Microbiology 2020 webinar is a unique and exciting opportunity, have been designed in an interdisciplinary manner with a multitude of tracks to showcase the latest advancements and new
Microbiology Testing Market Laborious Pace of 2025
Global Microbiology Testing Market: Snapshot The global market for microbiology testing is estimated to expand at a promising pace in the next few years owing to the massive rise in the awareness level among patients about the variety of rampant chronic diseases, respiratory infections, and inflammatory conditions. Rapid developments in the field of testing equipment and data processing technologies have also massively favored the market in the recent years. In the
Automated Microbiology MarketAnalysis 2016-2024
Automated microbiology is an advanced technique in the field of microbiology that enables the delivery of more accurate and quicker results. The advent of automation in microbiology is likely to boost productivity, reliability, and efficiency in molecular testing. The expertise of professionals that was previously engaged in repetitive tasks can now be directed in more important areas. View Report- https://www.transparencymarketresearch.com/automated-microbiology-market-size.html Based on end users, the global market for automated microbiology can be
Industrial Microbiology Market Growth – Market Report 2025
Qyresearchreports include new market research report “2018-2025 Industrial Microbiology Report on Global and United States Market,Status and Forecast,by Players,Types and Applications” to its huge collection of research reports. This report studies the global Industrial Microbiology market, analyzes and researches the Server Management Software development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like 3M Axon Lab AG Becton Dickinson
Artificial intelligence for industrial microbiology
Munich, Germany, November 23, 2017 - vermicon AG, the specialist for microbiological solutions, is launching the new Scan VIT® system for analysis of microorganisms. It is able to quantify and specifically identify single cells directly and without time-consuming enrichment steps. A fully automated analysis evaluation is provided by the intelligent VIT® Vision software, which is the centerpiece of the new, patented technology. In contrast to conventional rapid test methods, the
Automated Microbiology Market Research Report 2016
Global Automated Microbiology Market: Overview Automated microbiology is an advanced technique in the field of microbiology that enables the delivery of more accurate and quicker results. The advent of automation in microbiology is likely to boost productivity, reliability, and efficiency in molecular testing. The expertise of professionals that was previously engaged in repetitive tasks can now be directed in more important areas. View Report @ http://www.transparencymarketresearch.com/automated-microbiology-market-size.html Based on end users, the global market